Abbott has commenced the first subject procedures with its transcatheter aortic valve implantation (TAVI) system to treat symptomatic severe aortic stenosis. This investigational balloon ...

Nov. 25, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for ...

The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's NavitorTM TAVI system for aortic stenosis, a common and life-threatening heart valve disease The ...

Abbott Laboratories, Inc. ABT recently announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating ...

The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's Navitor™ TAVI system for aortic stenosis, a common and life-threatening heart valve disease The ...

The year saw much-anticipated data on the value of early TAVI vs surveillance, plus two new tricuspid device approvals.